PHR

Phreesia Inc

TMT, Software


Presented:02/02/2024
Price:$26.71
Cap:$1.49B
Current Price:$21.03
Cap:$1.21B

Presented

Date02/02/2024
Price$26.71
Market Cap$1.49B
Ent Value$0.67B
P/E RatioN/A
Book Value$4.76
Div Yield0%
Shares O/S55.63M
Ave Daily Vol664,441
Short Int4.72%

Current

Price$21.03
Market Cap$1.21B
Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Publicly traded companies mentioned herein: Phreesia Inc (PHR)

Highlights

The presenter is long shares of Phreesia Inc (PHR), which primarily provides electronic health record software to smaller doctors’ offices, as well as offering payments and advertising solutions as part of the ecosystem. Management invested heavily in growth post-COVID at the expense of profitability when investors started prioritizing profitability, causing the stock to plummet. More recently, the company seems to have committed to profitability, and he believes PHR can sustain DD% growth over the long term with EBITDA margins expanding toward 15%. Given this bullish outlook, the current $27 share price (3.5x consensus NTM revenue) seems like an attractive entry point.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.